Coenzyme Q10 protects ischemic myocardium in an open-chest swine model

D. Atar, S. A. Mortensen, H. Flachs, W. R. Herzog

Research output: Contribution to journalArticle

Abstract

Myocardial stunning, defined as a reversible decrease in contractility after ischemia and reperfusion, may be a manifestation of reperfusion injury caused by free oxygen radical damage. The aim of this study was to test the hypothesis that pretreatment with coenzyme Q10 (ubiquinone), believed to act as a free radical scavenger, reduces myocardial stunning in a porcine model. Twelve swine were randomized to receive either oral supplementation with coenzyme Q10 or placebo for 20 days. A normothermic open-chest model was used with short occlusion (8 min) of the distal left descending coronary artery followed by reperfusion. Regional contractile function was measured with epicardial Doppler crystals in ischemic and nonischemic segments by measuring thickening fraction of the left ventricular wall during systole. Stunning time was defined as the elapsed time of reduced contractility until return to baseline. Coenzyme Q10 concentrations were measured in blood and homogenized myocardial tissue by high performance liquid chromatography. Plasma levels of reduced coenzyme Q10 (ubiquinol) were higher in swine pretreated with the experimental medication as compared to placebo (mean 0.45 mg/l versus 0.11 mg/l, respectively). Myocardial tissue concentrations, however, did not show any changes (mean 0.79 μg/mg dry weight versus 0.74 μg/mg). Stunning time was significantly reduced in coenzyme Q10 pretreated animals (13.7±7.7 min versus 32.8±3.1 min, P <0.01). In conclusion, chronic pretreatment with coenzyme Q10 protects ischemic myocardium in an open-chest swine model. The beneficial effect of coenzyme Q10 on myocardial stunning may be due to protection from free radical mediated reperfusion injury. This protective effect seems to be generated by a humoral rather than intracellular mechanism.

Original languageEnglish (US)
JournalThe Clinical Investigator
Volume71
Issue number8 Supplement
DOIs
StatePublished - Aug 1993
Externally publishedYes

Fingerprint

coenzyme Q10
Myocardium
Myocardial Stunning
Swine
Thorax
Reperfusion Injury
Reperfusion
Free Radicals
Placebos
Free Radical Scavengers
Ubiquinone
Systole
Reactive Oxygen Species
Coronary Vessels
Ischemia
High Pressure Liquid Chromatography
Weights and Measures

Keywords

  • Animal model
  • Coenzyme Q
  • Myocardial contractility
  • Myocardial ischemia
  • Reperfusion injury

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Atar, D., Mortensen, S. A., Flachs, H., & Herzog, W. R. (1993). Coenzyme Q10 protects ischemic myocardium in an open-chest swine model. The Clinical Investigator, 71(8 Supplement). https://doi.org/10.1007/BF00226849

Coenzyme Q10 protects ischemic myocardium in an open-chest swine model. / Atar, D.; Mortensen, S. A.; Flachs, H.; Herzog, W. R.

In: The Clinical Investigator, Vol. 71, No. 8 Supplement, 08.1993.

Research output: Contribution to journalArticle

Atar, D, Mortensen, SA, Flachs, H & Herzog, WR 1993, 'Coenzyme Q10 protects ischemic myocardium in an open-chest swine model', The Clinical Investigator, vol. 71, no. 8 Supplement. https://doi.org/10.1007/BF00226849
Atar, D. ; Mortensen, S. A. ; Flachs, H. ; Herzog, W. R. / Coenzyme Q10 protects ischemic myocardium in an open-chest swine model. In: The Clinical Investigator. 1993 ; Vol. 71, No. 8 Supplement.
@article{f087dcc8d1b04582a3233c57311fdc7a,
title = "Coenzyme Q10 protects ischemic myocardium in an open-chest swine model",
abstract = "Myocardial stunning, defined as a reversible decrease in contractility after ischemia and reperfusion, may be a manifestation of reperfusion injury caused by free oxygen radical damage. The aim of this study was to test the hypothesis that pretreatment with coenzyme Q10 (ubiquinone), believed to act as a free radical scavenger, reduces myocardial stunning in a porcine model. Twelve swine were randomized to receive either oral supplementation with coenzyme Q10 or placebo for 20 days. A normothermic open-chest model was used with short occlusion (8 min) of the distal left descending coronary artery followed by reperfusion. Regional contractile function was measured with epicardial Doppler crystals in ischemic and nonischemic segments by measuring thickening fraction of the left ventricular wall during systole. Stunning time was defined as the elapsed time of reduced contractility until return to baseline. Coenzyme Q10 concentrations were measured in blood and homogenized myocardial tissue by high performance liquid chromatography. Plasma levels of reduced coenzyme Q10 (ubiquinol) were higher in swine pretreated with the experimental medication as compared to placebo (mean 0.45 mg/l versus 0.11 mg/l, respectively). Myocardial tissue concentrations, however, did not show any changes (mean 0.79 μg/mg dry weight versus 0.74 μg/mg). Stunning time was significantly reduced in coenzyme Q10 pretreated animals (13.7±7.7 min versus 32.8±3.1 min, P <0.01). In conclusion, chronic pretreatment with coenzyme Q10 protects ischemic myocardium in an open-chest swine model. The beneficial effect of coenzyme Q10 on myocardial stunning may be due to protection from free radical mediated reperfusion injury. This protective effect seems to be generated by a humoral rather than intracellular mechanism.",
keywords = "Animal model, Coenzyme Q, Myocardial contractility, Myocardial ischemia, Reperfusion injury",
author = "D. Atar and Mortensen, {S. A.} and H. Flachs and Herzog, {W. R.}",
year = "1993",
month = "8",
doi = "10.1007/BF00226849",
language = "English (US)",
volume = "71",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "8 Supplement",

}

TY - JOUR

T1 - Coenzyme Q10 protects ischemic myocardium in an open-chest swine model

AU - Atar, D.

AU - Mortensen, S. A.

AU - Flachs, H.

AU - Herzog, W. R.

PY - 1993/8

Y1 - 1993/8

N2 - Myocardial stunning, defined as a reversible decrease in contractility after ischemia and reperfusion, may be a manifestation of reperfusion injury caused by free oxygen radical damage. The aim of this study was to test the hypothesis that pretreatment with coenzyme Q10 (ubiquinone), believed to act as a free radical scavenger, reduces myocardial stunning in a porcine model. Twelve swine were randomized to receive either oral supplementation with coenzyme Q10 or placebo for 20 days. A normothermic open-chest model was used with short occlusion (8 min) of the distal left descending coronary artery followed by reperfusion. Regional contractile function was measured with epicardial Doppler crystals in ischemic and nonischemic segments by measuring thickening fraction of the left ventricular wall during systole. Stunning time was defined as the elapsed time of reduced contractility until return to baseline. Coenzyme Q10 concentrations were measured in blood and homogenized myocardial tissue by high performance liquid chromatography. Plasma levels of reduced coenzyme Q10 (ubiquinol) were higher in swine pretreated with the experimental medication as compared to placebo (mean 0.45 mg/l versus 0.11 mg/l, respectively). Myocardial tissue concentrations, however, did not show any changes (mean 0.79 μg/mg dry weight versus 0.74 μg/mg). Stunning time was significantly reduced in coenzyme Q10 pretreated animals (13.7±7.7 min versus 32.8±3.1 min, P <0.01). In conclusion, chronic pretreatment with coenzyme Q10 protects ischemic myocardium in an open-chest swine model. The beneficial effect of coenzyme Q10 on myocardial stunning may be due to protection from free radical mediated reperfusion injury. This protective effect seems to be generated by a humoral rather than intracellular mechanism.

AB - Myocardial stunning, defined as a reversible decrease in contractility after ischemia and reperfusion, may be a manifestation of reperfusion injury caused by free oxygen radical damage. The aim of this study was to test the hypothesis that pretreatment with coenzyme Q10 (ubiquinone), believed to act as a free radical scavenger, reduces myocardial stunning in a porcine model. Twelve swine were randomized to receive either oral supplementation with coenzyme Q10 or placebo for 20 days. A normothermic open-chest model was used with short occlusion (8 min) of the distal left descending coronary artery followed by reperfusion. Regional contractile function was measured with epicardial Doppler crystals in ischemic and nonischemic segments by measuring thickening fraction of the left ventricular wall during systole. Stunning time was defined as the elapsed time of reduced contractility until return to baseline. Coenzyme Q10 concentrations were measured in blood and homogenized myocardial tissue by high performance liquid chromatography. Plasma levels of reduced coenzyme Q10 (ubiquinol) were higher in swine pretreated with the experimental medication as compared to placebo (mean 0.45 mg/l versus 0.11 mg/l, respectively). Myocardial tissue concentrations, however, did not show any changes (mean 0.79 μg/mg dry weight versus 0.74 μg/mg). Stunning time was significantly reduced in coenzyme Q10 pretreated animals (13.7±7.7 min versus 32.8±3.1 min, P <0.01). In conclusion, chronic pretreatment with coenzyme Q10 protects ischemic myocardium in an open-chest swine model. The beneficial effect of coenzyme Q10 on myocardial stunning may be due to protection from free radical mediated reperfusion injury. This protective effect seems to be generated by a humoral rather than intracellular mechanism.

KW - Animal model

KW - Coenzyme Q

KW - Myocardial contractility

KW - Myocardial ischemia

KW - Reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=0027725985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027725985&partnerID=8YFLogxK

U2 - 10.1007/BF00226849

DO - 10.1007/BF00226849

M3 - Article

C2 - 8241692

VL - 71

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 8 Supplement

ER -